Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.

Here are three of the biggest mistakes that doctors say people make while taking Ozempic and similar medications. 🩺 SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...

These are referred to as compounded drugs, which, while containing some of the same ingredients, are not identical to the ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of GLP-1 obesity drugs. Front and center of this is Novo Nordisk (NYSE: NVO), ...

Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...